STOCK TITAN
  1. Home
  2. News
  3. PHR

Phreesia, Inc. - PHR STOCK NEWS

Welcome to our dedicated page for Phreesia news (Ticker: PHR), a resource for investors and traders seeking the latest updates and insights on Phreesia stock.

Phreesia, Inc. (symbol: PHR) is a leading provider of comprehensive software solutions designed to enhance the operational and financial performance of healthcare organizations. Through its innovative SaaS-based technology platform, Phreesia enables medical groups of all sizes to streamline their administrative, financial, and clinical operations, thereby allowing healthcare staff to focus more on delivering exceptional patient care.

The Phreesia Platform offers a robust suite of integrated solutions that manage various aspects of patient interactions. These solutions include patient access, registration, payments, and clinical support, all aimed at optimizing patient health outcomes. By activating patients in their care, Phreesia ensures that healthcare providers can offer more personalized and efficient services.

Phreesia's flexible and scalable platform is trusted by leading healthcare organizations to revolutionize their point of service. The platform encompasses a wide range of technologies and services, from initial patient contact and registration to appointment scheduling, payment processing, and post-appointment patient surveys. This comprehensive range of services drives tangible results, enhancing both patient and provider experiences.

Recent achievements and current projects at Phreesia include continuous updates to their software to ensure compatibility with the latest technological advancements and regulatory requirements. The company also focuses on forming strategic partnerships that further enhance the capabilities of their platform.

In terms of financial condition, Phreesia has shown consistent growth, driven by the increasing demand for efficient healthcare management solutions. The company's ability to adapt to the evolving needs of the healthcare industry makes it a significant player in the market.

News

Phreesia Sets Release Date for Fiscal First Quarter 2025 Results

Rhea-AI Summary

Phreesia, Inc. (NYSE: PHR) has announced the release date for its fiscal first quarter 2025 financial results, set for after market trading on Thursday, May 30, 2024. The company will issue a press release and a quarterly stakeholder letter, to be posted on their investor website at ir.phreesia.com. A conference call to discuss the results will take place at 5PM Eastern Time on the same day. Phreesia is a leader in patient activation, enabling approximately 150 million patient visits in 2023 and offering digital solutions to enhance the patient experience and improve healthcare outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.12%
Tags
earnings
-
News

Phreesia Announces Jack Callahan as New Chief Technology Officer

Rhea-AI Summary
Phreesia appoints Jack Callahan as Chief Technology Officer, succeeding Dan Nathan. Callahan, with 14 years at Phreesia, aims to enhance the platform to address healthcare challenges. Nathan remains as Senior Engineering Advisor. CEO Chaim Indig lauds Nathan's contributions and trusts Callahan's leadership for future product innovation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.05%
Tags
none
-
News

Phreesia Announces Fourth Quarter Fiscal 2024 Results

Rhea-AI Summary
Phreesia, Inc. (PHR) reports strong financial results for Q4 and FY 2024, with revenue up 27% year-over-year. Despite a net loss, the company shows growth in AHSCs and total revenue. The outlook for FY 2025 indicates continued growth and improved Adjusted EBITDA.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.76%
Tags
earnings
News

Phreesia’s Hilary Hatch Again Named to the 2024-2025 NQF Leadership Consortium

Rhea-AI Summary
Phreesia's Chief Clinical Officer, Dr. Hilary Hatch, selected for NQF's 2024-2025 Leadership Consortium, showcasing dedication to healthcare quality and patient-centered care. Dr. Hatch leads clinical programs, research partnerships, and patient engagement efforts at Phreesia, emphasizing the importance of patient activation in improving health outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.48%
Tags
none
-
News

New Data Shows That Engaging Patients with Relevant Cancer-Prevention Information During Check-In Increases Screening Rates

Rhea-AI Summary
Phreesia's breast cancer-prevention campaign resulted in 32% of patients requesting a screening, showcasing the positive impact of their platform on increasing cancer screening rates.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.32%
Tags
none
-
News

Phreesia Sets Release Date for Fiscal Fourth Quarter 2024 Results

Rhea-AI Summary
Phreesia, Inc. (PHR) will release its fiscal fourth quarter 2024 financial results on March 14, 2024, followed by a conference call to discuss the results. The company's quarterly stakeholder letter and press release will be available on its investor website. Participants can join the conference call via phone or webcast, with a replay available for on-demand listening.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.66%
Tags
earnings
News

Phreesia Joins Call to Action to Improve Adult Vaccination Rates

Rhea-AI Summary
Phreesia has joined the National Adult and Influenza Immunization Summit’s Call to Action for Adult Immunizations campaign to improve adult vaccination rates. The campaign aims to encourage healthcare providers to take action to protect adults from preventable illness, disability, and death. More than three in four adults are missing routinely recommended vaccines, and low vaccination rates have worsened due to preventive care put on hold during the COVID-19 pandemic. Phreesia's vaccine management tools support healthcare organizations by collecting critical information, engaging patients, and giving them the resources they need to make informed decisions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.49%
Tags
none
-
News

Phreesia’s Audrey Gato Named as a Top Woman Leader in SaaS

Rhea-AI Summary
Phreesia's Vice President of Client Solutions, Audrey Gato, has been named to The Software Report’s list of the Top 50 Women Leaders in SaaS of 2023, marking the sixth consecutive year a female leader from Phreesia has been recognized. Gato's role involves overseeing client implementation and account management for Phreesia’s payer and managed service offerings, as well as leading client efforts around clinical programs such as the Kidney Care Choices (KCC) Model and Merit-based Incentive Payment System (MIPS). The Software Report highlighted the diverse leadership roles of the award recipients, emphasizing their adept leadership within the SaaS industry. Gato expressed her honor in being recognized and emphasized Phreesia's commitment to introducing new initiatives and products to serve clients and the healthcare industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.75%
Tags
none
-
News

Phreesia’s Post-Script Engagement named one of PM360’s 2023 Most Innovative Technologies

Rhea-AI Summary
Phreesia (PHR) has been recognized by PM360 for its innovative medication adherence solution, Post-Script Engagement, being named to the list of 2023 Most Innovative Marketing Technologies or Services. The offering was selected as one of 56 overall honorees, and one of just 8 technologies or services to be recognized for marketing innovation. Post-Script Engagement provides patients with resources to adhere to their medication as soon as their prescription is written, delivering curated content in a secure manner. The engagement also includes a survey to measure patients' likelihood to fill their prescription, providing insights to help doctors tailor their interactions with patients to address their unique adherence challenges. Phreesia's VP of Product Management, Kristin Roberts, expressed pride in offering Post-Script Engagement as part of a medication adherence product suite that supports patients, providers, and life sciences partners.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.05%
Tags
none
News

Phreesia Announces Third Quarter Fiscal 2024 Results

Rhea-AI Summary
Phreesia, Inc. (NYSE: PHR) announced its fiscal third-quarter results, reporting total revenue of $91.6 million, a 25% increase from the previous year. The net loss was $31.9 million, down from $40.2 million in the prior year. The company acquired ConnectOnCall.com, LLC for $13.9 million and replaced its credit facility with a new 5-year $50 million senior secured asset-based revolving credit facility with Capital One, N.A. Phreesia is maintaining its revenue outlook for fiscal year 2024 at $353 million to $356 million, with a year-over-year growth of 26% to 27%. The company is introducing its revenue outlook for fiscal 2025, expecting revenue to be in the range of $424 million to $434 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
21.22%
Tags
earnings

FAQ

What is the current stock price of Phreesia (PHR)?

The current stock price of Phreesia (PHR) is $25.16 as of December 20, 2024.

What is the market cap of Phreesia (PHR)?

The market cap of Phreesia (PHR) is approximately 1.4B.

What does Phreesia, Inc. do?

Phreesia, Inc. provides comprehensive software solutions that improve the operational and financial performance of healthcare organizations by managing patient access, registration, payments, and clinical support.

What is the Phreesia Platform?

The Phreesia Platform is a robust suite of integrated solutions designed to manage patient interactions, including access, registration, payments, and clinical support.

How does Phreesia benefit healthcare organizations?

Phreesia benefits healthcare organizations by streamlining administrative, financial, and clinical operations, allowing staff to focus more on patient care and improving overall efficiency.

What are some of Phreesia's recent achievements?

Recent achievements include continuous software updates, ensuring compliance with the latest technological advancements and regulatory requirements, and forming strategic partnerships to enhance their platform's capabilities.

What makes Phreesia's platform scalable and flexible?

Phreesia's platform is designed to be adaptable to the varying needs of healthcare organizations of all sizes, offering scalable solutions that can grow with the organization.

Who uses Phreesia's services?

Leading healthcare organizations and medical groups of all sizes use Phreesia's services to revolutionize their point of service and improve patient care.

What is Phreesia's approach to patient activation?

Phreesia activates patients in their care by providing tools and technologies that engage them throughout their healthcare journey, optimizing health outcomes.

How does Phreesia enhance patient-provider interactions?

By offering integrated solutions for access, registration, payments, and clinical support, Phreesia enhances patient-provider interactions, making them more efficient and personalized.

What are some key features of the Phreesia Platform?

Key features include patient access management, registration, payment processing, appointment scheduling, and post-appointment surveys.

How is Phreesia performing financially?

Phreesia has shown consistent financial growth, driven by the increasing demand for efficient healthcare management solutions.

Stock PHR logo
Phreesia, Inc.

NYSE:PHR

PHR Rankings

#2250 Ranked by Market Cap
N/A Ranked by Dividends

PHR Stock Data

1.40B
55.28M
4.62%
100.81%
5.07%
Health Information Services
Services-business Services, Nec
Link
United States of America
WILMINGTON